Sarah Sloan - Concepedia

Author

Sarah Sloan

Brigham and Women's Hospital

Also Known As

Katherine Shin, S. Sloan, Sarah Sloan

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Thrombolysis in Myocardial Infarction Study Group Harvard University Akershus University Hospital University of Oslo

About

Sarah Sloan is an author at Brigham and Women's Hospital specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	355
2	Public Health	2	2	109
3	Biomedical Engineering	1	1	99
4	Emergency Medicine	1	1	25
5	Epidemiology	1	1	10

Sarah Sloan

Publications

Citations

H-Index

Page 1

	Year	Citations
What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes? Sripal Bangalore, Jie Qin, Sarah Sloan, Circulation	2010	223
Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease Marc S. Sabatine, David A. Morrow, James A. de Lemos, Circulation	2011	143
Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome C. Michael Gibson, Yuri B. Pride, Claudia P. Hochberg, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseAcute Coronary SyndromeClinical OutcomesPreventive Cardiology	2009	126
Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: Observations from the PROTECT-TIMI 30 Trial Sean R. Wilson, Marc S. Sabatine, Eugene Braunwald, American Heart Journal Protect-timi 30NanomedicineCardiovascular DiseaseMedicineUnstable Angina	2009	99
Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease Jacob A. Udell, David A. Morrow, Petr Jarolı́m, Journal of the American College of Cardiology Cardiovascular PrognosisFibrosisAngiogenesisCardiovascular DiseaseEndothelial Dysfunction	2014	95
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators Wojciech Zaręba, James P. Daubert, Christopher A. Beck, Journal of the American College of Cardiology	2018	78
Dynamic TIMI Risk Score for STEMI Sameer Amin, David A. Morrow, Eugene Braunwald, Journal of the American Heart Association	2013	74
Clinical Features and Outcomes of Women With Unstable Ischemic Heart Disease Jessica L. Mega, Judith S. Hochman, Benjamin M. Scirica, Circulation	2010	68
Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction Susan Cheng, David A. Morrow, Sarah Sloan, Circulation	2009	45
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome Babak Nazer, Kausik K. Ray, Sarah Sloan, European Heart Journal	2011	32

Page 1